InfectiousICD-10: B02About 1 in 3 people in the US will develop shingles in their lifetime

Shingles

Also known as: Herpes zoster

Shingles is a viral infection caused by the reactivation of the varicella-zoster virus, the same virus that causes chickenpox. It produces a painful, blistering rash that typically appears as a stripe of blisters on one side of the body or face. Shingles is most common in older adults and people with weakened immune systems, and vaccination can significantly reduce the risk.

Last updated November 10, 2026

Understanding Shingles

Shingles (herpes zoster) is a reactivation of the varicella-zoster virus that has lain dormant in nerve ganglia since a childhood bout of chickenpox or, far less often, since chickenpox vaccination. About one million Americans get it each year, roughly one in three people will have it in their lifetime, and the incidence climbs steeply with age: around 2 per 1,000 person-years under 50, 7 to 8 per 1,000 in the 60s and more than 10 per 1,000 over 80. By age 85 about half of unvaccinated adults will have had an episode. Anyone who has had chickenpox can get it, including children, but conditions and drugs that suppress immunity (chemotherapy, high-dose steroids, JAK inhibitors, HIV, transplant medication) bring it forward and make it more severe. Women are affected slightly more than men, and a first episode is usually also the last: recurrence runs about 5 to 6 percent over the following decade.

After chickenpox the virus persists in the dorsal root and cranial nerve ganglia, held in check by T-cell immunity that wanes with age and illness. When it escapes, it travels down the nerve to the skin, which is why the rash is strictly one-sided and follows a single dermatome, most often on the trunk or in the first division of the trigeminal nerve across the forehead and eye. The sequence is prodromal pain, itch or tingling for 1 to 5 days, then red bumps that become clusters of blisters over 3 to 5 days, crust by 7 to 10 days and heal in 2 to 4 weeks; the blister fluid is infectious to non-immune people until it crusts. The damaged nerve is the real problem. Postherpetic neuralgia (PHN), pain persisting 90 days or more after the rash, affects 10 to 18 percent of patients overall but is strongly age-dependent: uncommon under 40, roughly 1 in 5 after 60 and up to 1 in 3 after 80. Eye involvement, 10 to 20 percent of cases, can threaten sight.

Antivirals are the core of acute treatment and the clock matters: valacyclovir, famciclovir or acyclovir started within 72 hours of the rash shorten viral shedding, speed healing by a few days and reduce the severity and duration of acute pain. The 2014 Cochrane review was less flattering on the long-term outcome: acyclovir did not significantly reduce PHN at four or six months, and the data for newer agents were insufficient, so antivirals should be understood as treating the acute illness rather than reliably preventing neuralgia. Established PHN is treated with gabapentin or pregabalin, tricyclics such as nortriptyline, 5 percent lidocaine patches and the 8 percent capsaicin patch. Prevention is where the numbers are striking: the recombinant zoster vaccine (Shingrix, two doses 2 to 6 months apart) was 97 percent effective against shingles in 15,411 adults over 50 (ZOE-50) and 90 percent in 13,900 adults over 70 (ZOE-70), reduced PHN by about 90 percent, and remained roughly 80 percent effective at 10 years. ACIP recommends it for everyone 50 and over and for immunocompromised adults from age 19.

Natural approaches have a small, mostly symptomatic place, and some popular ones have no evidence at all. Capsaicin is the one plant-derived treatment with real data, but only for established PHN and never on an active rash. Lidocaine patches, sold over the counter at 4 percent, have only low-quality supporting evidence for PHN, and the trials used the 5 percent prescription patch. Lysine is widely recommended online by extrapolation from cold sores; there is no trial of lysine in shingles, the cold-sore evidence itself is weak and inconsistent, and it has no demonstrated action against varicella-zoster. Vitamin C infusions and vitamin B12 injections have small trials suggesting lower pain scores in the weeks after the rash, worth knowing about but never a reason to delay antivirals. Cool compresses, calamine and colloidal oatmeal baths are reasonable during the blistering phase. Essential oils, colloidal silver, apple cider vinegar, bleach baths, manuka honey, elderberry and 'immune' herbal blends have no trial in shingles, and anything that breaks the blisters invites bacterial infection and scarring.

The single most common mistake is waiting. The first day or two of shingles is often just one-sided burning or stabbing pain with no rash, which gets blamed on a pulled muscle, kidney stone, sciatica or even a heart problem; by the time blisters appear and someone looks it up, the 72-hour window is half gone. Any new one-sided band of pain in an adult over 50, especially with a few bumps appearing in it, deserves a same-day call, and a rash near the eye or the tip of the nose, in the ear canal, or in anyone immunosuppressed is an urgent assessment because of the risk to vision, hearing and the brain. The second mistake is assuming a past episode or a Zostavax shot in the 2010s means protection; Zostavax was about 51 percent effective and waned to little within 8 years, and neither it nor prior shingles substitutes for Shingrix. The third is giving up on PHN as untreatable: most people improve over 6 to 12 months, and combinations of treatments help many of the rest.

At a Glance

Common symptoms
Pain, burning, or tingling sensation on one side of the body, Red rash that appears a few days after the pain, Fluid-filled blisters that break open and crust over
Main treatments
Antiviral medications such as acyclovir, valacyclovir, or famciclovir started within 72 hours, Pain relief with over-the-counter or prescription analgesics, Topical capsaicin or lidocaine patches for postherpetic neuralgia
Category
Infectious · About 1 in 3 people in the US will develop shingles in their lifetime
See a doctor if
Pain or rash near the eye, which can lead to vision loss

Symptoms

Pain, burning, or tingling sensation on one side of the body
Red rash that appears a few days after the pain
Fluid-filled blisters that break open and crust over
Itching at the rash site
Fever and chills
Headache
Fatigue
Sensitivity to touch in the affected area

Causes

  • Reactivation of the dormant varicella-zoster virus in nerve tissue
  • Weakened immune system allowing viral reactivation
  • Age-related decline in immune function

Risk Factors

  • Age over 50 years
  • Previous chickenpox infection
  • Immunosuppressive medications or conditions
  • Chronic stress or illness
  • Cancer treatments such as chemotherapy or radiation

Diagnosis

  • Clinical examination of the characteristic rash pattern
  • PCR testing of blister fluid or skin scrapings
  • Direct fluorescent antibody testing
  • Viral culture in atypical cases

Treatment

  • Antiviral medications such as acyclovir, valacyclovir, or famciclovir started within 72 hours
  • Pain relief with over-the-counter or prescription analgesics
  • Topical capsaicin or lidocaine patches for postherpetic neuralgia
  • Corticosteroids to reduce inflammation in some cases
  • Cool compresses to soothe blisters

Natural remedies for shingles: what the evidence says

Ranked by the strength of human evidence for shingles specifically. These sit alongside medical care, not in place of it.

  1. Capsaicin

    Moderate evidence

    For established postherpetic neuralgia, not the acute rash. A 2017 Cochrane review of the 8 percent capsaicin patch (8 trials, 2,488 people with neuropathic pain) found that in PHN a single 60-minute application gave at least 30 percent pain relief for 8 to 12 weeks in about 1 extra person for every 11 treated compared with a low-dose control patch, and it is FDA-approved for PHN. The 0.075 percent cream has older, weaker data: in a 6-week trial of 143 patients, 64 percent improved versus 25 percent on vehicle, but a 2012 Cochrane review judged the low-concentration evidence poor.

    Studied dose
    8 percent patch applied in a clinic for 60 minutes to healed skin, repeated no sooner than every 3 months; or 0.025 to 0.075 percent cream 3 to 4 times daily for at least 4 to 6 weeks, started only after the rash has fully healed.
    Cautions
    Never on active blisters, broken skin, the face near the eyes or mucous membranes. Burning affects roughly a third of cream users and is worse if applied inconsistently; wear gloves and wash hands. The patch can transiently raise blood pressure and needs clinic monitoring.
  2. Vitamin B12

    Preliminary evidence

    In a single-center randomized trial of 98 patients with subacute herpetic neuralgia, 1,000 micrograms of methylcobalamin injected under the skin near the painful area daily for 6 days reduced pain scores and improved quality of life over the following 4 weeks more than lidocaine injections or oral B12. The data come from one Chinese research group and a clinic-administered form; there is no trial of oral B12 tablets in shingles pain.

    Studied dose
    Studied form: 1,000 micrograms methylcobalamin subcutaneously, daily for 6 days, given by a clinician. Oral 1,000 micrograms daily is safe but untested for this purpose.
    Cautions
    Very safe. More useful than supplementing blindly is checking a serum vitamin B12 level if you are over 60, vegan, or taking metformin or acid-suppressing drugs, because B12 deficiency causes a neuropathy that can be mistaken for, or worsen, postherpetic pain.
  3. Vitamin C

    Preliminary evidence

    A randomized placebo-controlled trial of 87 Korean adults with acute shingles given intravenous ascorbic acid (5 g on three occasions over 5 days) alongside standard antivirals found lower pain scores at 8 and 16 weeks but no clear reduction in the proportion developing PHN. A 41-patient crossover trial found intravenous vitamin C reduced spontaneous pain in established PHN over 2 weeks. All of this involved infusions in a clinic; oral vitamin C has no trial in shingles.

    Studied dose
    Studied as 2.5 to 5 g intravenous ascorbic acid per session, clinic-administered. Oral doses of 500 to 1,000 mg per day are safe but have not been tested for shingles.
    Cautions
    High-dose intravenous vitamin C is contraindicated in G6PD deficiency (hemolysis) and in kidney impairment or a history of oxalate kidney stones. Oral doses above 2 g cause loose stools, and high doses can give false readings on some glucose meters.

What matters day to day

  • Call the same day that one-sided burning pain or the first bumps appear: antivirals work best within 72 hours of the rash, and each day of delay narrows the benefit on acute pain and healing.
  • Keep the rash covered with a loose, non-stick dressing until every blister has crusted, and avoid contact with pregnant women who have not had chickenpox, babies under 12 months and anyone immunosuppressed: the fluid, not the air, carries the virus, and a covered rash on the trunk poses little risk.
  • Use cool, wet compresses for 10 to 15 minutes several times a day, then let the skin air-dry: cooling calms the burning, dries weeping blisters and reduces the itch that leads to scratching, infection and scarring.
  • Treat the pain properly from day one and ask for a plan if over-the-counter drugs are not enough: severe acute pain is itself one of the strongest predictors of postherpetic neuralgia, alongside age over 60, a severe rash and prodromal pain before the rash.
  • Book Shingrix once the rash has healed, regardless of whether you had Zostavax or a previous episode: it was 97 percent effective in adults over 50 and about 80 percent effective 10 years out, and since 2023 Medicare Part D covers it with no copay.
  • Keep fingernails short and resist scratching or popping blisters: bacterial superinfection with staph or strep is the most common early complication, and open blisters heal with more scarring and pigment change.

Prevention

  • Shingrix vaccine recommended for adults 50 and older
  • Vaccination for immunocompromised adults as advised by their doctor
  • Avoiding contact with people who have not had chickenpox while blisters are active

When to See a Doctor

  • Pain or rash near the eye, which can lead to vision loss
  • Widespread rash suggesting a weakened immune system
  • Rash that does not improve within 10 days
  • Severe pain that disrupts daily activities

Frequently Asked Questions

References

  1. Lal H, Cunningham AL, Godeaux O, et al.. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. New England Journal of Medicine (2015)
  2. Cunningham AL, Lal H, Kovac M, et al.. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. New England Journal of Medicine (2016)
  3. Strezova A, Diez-Domingo J, Al Shawafi K, et al.. Long-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: interim efficacy, immunogenicity, and safety results up to 10 years after initial vaccination. Open Forum Infectious Diseases (2022)
  4. Dooling KL, Guo A, Patel M, et al.. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morbidity and Mortality Weekly Report (2018)
  5. Chen N, Li Q, Yang J, et al.. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews (2014)
  6. Derry S, Rice AS, Cole P, et al.. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews (2017)
  7. Derry S, Wiffen PJ, Moore RA, Quinlan J. Topical lidocaine for neuropathic pain in adults. Cochrane Database of Systematic Reviews (2014)
  8. Yawn BP, Saddier P, Wollan PC, et al.. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clinic Proceedings (2007)
  9. Xu G, Lv ZW, Feng Y, et al.. A single-center randomized controlled trial of local methylcobalamin injection for subacute herpetic neuralgia. Pain Medicine (2013)
  10. Centers for Disease Control and Prevention. Shingles (Herpes Zoster) (2024)View source

Related Conditions

Evidence-graded guides

Lab tests that relate to shingles

Have questions about Shingles?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.